Odyssean »

Doximity shares owned by Odyssean

Quarter-by-quarter ownership of Doximity (DOCS) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in Doximity

Tip: Access up to 7 years of quarterly data

All positions including Doximity held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Doximity by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.4M 115k 20.74

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding Doximity

BlackRock
Vanguard Portfolio Management
Vanguard Capital Management
D. E. Shaw & Co
ClearBridge Advisors
William Blair Investment Management
Carmignac Gestion
Goldman Sachs Group
State Street Corporation
Geode Capital Management
Deutsche Bank Aktiengesellschaft
Renaissance Technologies
Wellington Management Company
Capital World Investors
Federated Investors

View all funds holding Doximity